Agilent
Quest Diagnostics to Offer Agilent Companion Test for Mirati Therapeutics NSCLC Treatment
Agilent's companion diagnostic for Mirati's non-small cell lung cancer treatment Krazati will be available through Quest's national healthcare network.
In Brief This Week: MDxHealth, Agilent Technologies, IsoPlexis, IntegraGen, More
News items for the week of Jan. 9, 2023.
Evolving Akoya Biosciences Touts CDx Partnerships at JP Morgan Conference
The Marlborough, Massachusetts-based firm also announced new panels for its PhenoCycler-Fusion and PhenoImager HT spatial analysis platforms.
JP Morgan Healthcare Conference, Day 2: Thermo Fisher, Agilent, Roche, Seer, More
Highlights from the second day included Agilent's $725 million investment in nucleic acids manufacturing and Roche's development plans for an integrated mass spec platform.
Agilent, Akoya to Commercialize Workflow Tools for Tissue Biomarker Analysis
The end-to-end workflow products are intended for biopharmaceutical companies developing companion diagnostics for precision cancer therapeutics.